| Cohesive Pathways, Pc | |
|
141 Providence Rd Ste 100 Chapel Hill NC 27514-6219 | |
| (919) 636-5982 | |
| Not Available |
| Full Name | Cohesive Pathways, Pc |
|---|---|
| Speciality | Social Worker |
| Location | 141 Providence Rd Ste 100, Chapel Hill, North Carolina |
| Authorized Official Name and Position | Michael Jokich (PRESIDENT) |
| Authorized Official Contact | 9196365982 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Cohesive Pathways, Pc 101 Millingport Ct Chapel Hill NC 27517-7444 Ph: (919) 636-5982 | Cohesive Pathways, Pc 141 Providence Rd Ste 100 Chapel Hill NC 27514-6219 Ph: (919) 636-5982 |
| NPI Number | 1003034547 |
|---|---|
| Provider Enumeration Date | 04/22/2007 |
| Last Update Date | 12/27/2019 |
| Certification Date | 12/27/2019 |
| Medicare PECOS PAC ID | 7911058854 |
|---|---|
| Medicare Enrollment ID | O20090706000370 |
News Archive
In an article published in November 3 edition of Journal of the American Medical Association (JAMA), Chad Boult, MD, MPH, MBA, professor of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, calls for key improvements to primary care in order to improve the health of the nation's most costly patients-older adults with multiple chronic conditions.
Allscripts announced today that North Florida Surgeons (NFS) has selected the Allscripts Electronic Health Record (EHR) and Practice Management solution to automate and connect clinical and business functions for their 31 physicians and three mid-level providers.
Systemic sclerosis (SSc), also known as scleroderma, is characterized by the formation of fibrosis, or scar tissue, on internal organs as well as the skin.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
On behalf of the Honourable Dr. K. Kellie Leitch, Minister of Labour and Minister of Status of Women, Scott Armstrong, Parliamentary Secretary to the Minister of Labour, addressed health and safety experts at the 2015 Light the Way and Chemical Dependency Education and Rehabilitation Program National Conference in Cornwall today.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003034547 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | C006238 (North Carolina) | Primary |
| 1041C0700X | Social Worker - Clinical | C004163 (North Carolina) | Secondary |
| Provider Name | Elizabeth P Welton |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1871683185 PECOS PAC ID: 3971510215 Enrollment ID: I20090402000687 |
News Archive
In an article published in November 3 edition of Journal of the American Medical Association (JAMA), Chad Boult, MD, MPH, MBA, professor of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, calls for key improvements to primary care in order to improve the health of the nation's most costly patients-older adults with multiple chronic conditions.
Allscripts announced today that North Florida Surgeons (NFS) has selected the Allscripts Electronic Health Record (EHR) and Practice Management solution to automate and connect clinical and business functions for their 31 physicians and three mid-level providers.
Systemic sclerosis (SSc), also known as scleroderma, is characterized by the formation of fibrosis, or scar tissue, on internal organs as well as the skin.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
On behalf of the Honourable Dr. K. Kellie Leitch, Minister of Labour and Minister of Status of Women, Scott Armstrong, Parliamentary Secretary to the Minister of Labour, addressed health and safety experts at the 2015 Light the Way and Chemical Dependency Education and Rehabilitation Program National Conference in Cornwall today.
› Verified 5 days ago
| Provider Name | Michael Jokich |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1578789236 PECOS PAC ID: 3274684113 Enrollment ID: I20161013000741 |
News Archive
In an article published in November 3 edition of Journal of the American Medical Association (JAMA), Chad Boult, MD, MPH, MBA, professor of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, calls for key improvements to primary care in order to improve the health of the nation's most costly patients-older adults with multiple chronic conditions.
Allscripts announced today that North Florida Surgeons (NFS) has selected the Allscripts Electronic Health Record (EHR) and Practice Management solution to automate and connect clinical and business functions for their 31 physicians and three mid-level providers.
Systemic sclerosis (SSc), also known as scleroderma, is characterized by the formation of fibrosis, or scar tissue, on internal organs as well as the skin.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
On behalf of the Honourable Dr. K. Kellie Leitch, Minister of Labour and Minister of Status of Women, Scott Armstrong, Parliamentary Secretary to the Minister of Labour, addressed health and safety experts at the 2015 Light the Way and Chemical Dependency Education and Rehabilitation Program National Conference in Cornwall today.
› Verified 5 days ago
News Archive
In an article published in November 3 edition of Journal of the American Medical Association (JAMA), Chad Boult, MD, MPH, MBA, professor of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, calls for key improvements to primary care in order to improve the health of the nation's most costly patients-older adults with multiple chronic conditions.
Allscripts announced today that North Florida Surgeons (NFS) has selected the Allscripts Electronic Health Record (EHR) and Practice Management solution to automate and connect clinical and business functions for their 31 physicians and three mid-level providers.
Systemic sclerosis (SSc), also known as scleroderma, is characterized by the formation of fibrosis, or scar tissue, on internal organs as well as the skin.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
On behalf of the Honourable Dr. K. Kellie Leitch, Minister of Labour and Minister of Status of Women, Scott Armstrong, Parliamentary Secretary to the Minister of Labour, addressed health and safety experts at the 2015 Light the Way and Chemical Dependency Education and Rehabilitation Program National Conference in Cornwall today.
› Verified 5 days ago
Freedom House Recovery Center, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 104 New Stateside Dr, Chapel Hill, NC 27516 Phone: 919-942-2803 Fax: 919-942-2126 | |
Unc Mental Health Specialists Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 110 Conner Dr, Suite 4, Chapel Hill, NC 27514 Phone: 919-843-7449 | |
Darryl F. Smith, Phd, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 111 Cloister Ct, Suite 100, Chapel Hill, NC 27514 Phone: 919-402-4300 Fax: 919-420-4330 | |
Cpfs Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 Cloister Ct, Suite E, Chapel Hill, NC 27514 Phone: 919-408-3212 | |
Rachel Carroll, Lcsw, Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1818 Mlk Blvd # 105, Chapel Hill, NC 27514 Phone: 919-614-9791 | |
Unc Horizons Clinic In Chapel Hill Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 Manning Dr, Women's Hospital Obgyn Clinic C, Chapel Hill, NC 27514 Phone: 919-966-9803 Fax: 919-966-9169 |